International audienceBACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that they can use one or more specialized services during the study period. In 2004-2005, we conducted a national seroepidemiologic survey of DUs, based on a random sampling design using the Generalised Weight Share Method (GWSM) and on blood testing. METHODS: A cross-sectional multicenter survey was done among DUs having injected or snorted drugs at least once in their life. We conducted a two stage random survey of DUs selected ...
Background : Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) with people who ...
International audienceBackground and AimsAlthough people who inject drugs (PWID) are the core at‐ris...
AIMS: To estimate viral seroprevalences for HCV, HBV and HIV among belgian intravenous (IVDU) and n...
International audienceBACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been wide...
BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to...
International audienceAims: The primary aim of this study was to evaluate the impact of drug consump...
BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to...
BACKGROUND: Hepatitis C prevalence figures for people who use drugs in Belgium are scarce, and parti...
OBJECTIVE: In this paper, we review evidence of HCV prevalence among injecting drug users (IDUs) wor...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: The study's aim was to estimate the self-reported prevalence of Human Immunodeficiency V...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
BACKGROUND Hepatitis C virus (HCV) transmission in the UK is driven by injecting drug use. We explo...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
Background: Injecting drug use is an important risk factor for transmission of viral hepatitis, but ...
Background : Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) with people who ...
International audienceBackground and AimsAlthough people who inject drugs (PWID) are the core at‐ris...
AIMS: To estimate viral seroprevalences for HCV, HBV and HIV among belgian intravenous (IVDU) and n...
International audienceBACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been wide...
BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to...
International audienceAims: The primary aim of this study was to evaluate the impact of drug consump...
BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to...
BACKGROUND: Hepatitis C prevalence figures for people who use drugs in Belgium are scarce, and parti...
OBJECTIVE: In this paper, we review evidence of HCV prevalence among injecting drug users (IDUs) wor...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: The study's aim was to estimate the self-reported prevalence of Human Immunodeficiency V...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
BACKGROUND Hepatitis C virus (HCV) transmission in the UK is driven by injecting drug use. We explo...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
Background: Injecting drug use is an important risk factor for transmission of viral hepatitis, but ...
Background : Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) with people who ...
International audienceBackground and AimsAlthough people who inject drugs (PWID) are the core at‐ris...
AIMS: To estimate viral seroprevalences for HCV, HBV and HIV among belgian intravenous (IVDU) and n...